Article

ARG1 is a potential prognostic marker in metastatic and recurrent endometrial cancer

2023-07-18

Abstract excerpt

<title>Abstract</title> <p>Endometrial cancer (EC) is the most common gynecologic malignancy. While the majority of patients present with early-stage and low-grade EC and have an excellent prognosis, a subset has metastatic disease at presentation, or develops distant recurrence after initial treatment of the primary. However, the lack of prognostic biomarkers for metastatic EC is a critical barrier. Arginase 1 (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: faf5c209-86e5-5d59-998d-b996cc8fc9ec
DOI: 10.21203/rs.3.rs-2917380/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

ARG1 is a potential prognostic marker in metastatic and recurrent endometrial cancerDOI 10.21203/rs.3.rs-2917380/v1Read

ARG1 Is a Potential Prognostic Marker in Metastatic Endometrial Cancer.Semantic proximity Read

Loss of MIG-6 results in endometrial progesterone resistance via ERBB2Semantic proximity Read

Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future PerspectivesSemantic proximity Read

Breast cancer–derived GM-CSF regulates arginase 1 in myeloid cells to promote an immunosuppressive microenvironmentSemantic proximity Read

The Glutaminase Inhibitor Compound 968 Exhibits Potent in vitro and in vivo anti-tumor Effects in Endometrial CancerSemantic proximity Read

Landscape of Endometrial Cancer: Molecular Mechanisms, Biomarkers, and Target TherapySemantic proximity Read

[Thoughts on the molecular characteristics of endometrial cancer in clinical diagnosis and treatment].Semantic proximity Read

Molecular Network of Colorectal Cancer and Current Therapeutic OptionsSemantic proximity Read